Dad says autism ‘miracle drug’ drastically and immediately improved his son’s severe symptoms

By Published Oct. 1, 2026, 6:44 a.m. ET

Like most 4-and-a-half-year-olds, Lev Bielski loves playing with his big sister, spelling his favorite pastime “pool” on the letter board and cuddling with his parents on movie nights.

But it’s been a long journey for the golden-haired “surfer bro” who loves splashing in the water at surf camp and trying on Dad’s volunteer firefighter gear.

Up until four months ago, Lev was self-harming until he was black and blue, unable to make eye contact and keeping to himself in a corner all day. He was inching dangerously close to being confined by a punishing helmet and sedated with heavy antipsychotic meds to mitigate his severe autism that left him incapable of functioning by himself.

That was until research led the anguished couple to Yamo Pharmaceuticals, a decade-old clinical-stage biopharmaceutical company dedicated to treating the core symptoms of autism spectrum disorder with its “miracle drug” called L1-79.

They managed to get Lev the therapy before FDA approval thanks to the FDA’s expanded-access program — and the results, they said, were immediate.

“It was the next day,” Bielski said. “It was right away and other people in all the phases said the same thing.

Advertisement

“It changed everything for us,” he added, beaming over Lev’s “life-changing transformation.”

Overjoyed over his “miracle kid,” Bielski predicted the drug will be the “Ozempic of autism.”

(http://www.autoadmit.com/thread.php?thread_id=5915507&forum_id=2#50209166)